false
Catalog
7995-2 EA ORN Training – Addiction and the Adolesc ...
Recording
Recording
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In a session focused on adolescent substance use, Dr. Aishwarya Thakkar from Boston Children's Hospital discusses the impact of substances on the adolescent brain. The session highlights the developmental vulnerability of adolescents, whose brains, particularly the prefrontal cortex responsible for decision-making, are still maturing. Dr. Thakkar explains how adolescents are neurologically inclined to seek rewards, significantly increasing their susceptibility to substances like nicotine, cannabis, alcohol, and opioids.<br /><br />The talk covers research showing that substances like nicotine and cannabis can affect brain areas like the prefrontal cortex and hippocampus, altering reward mechanisms and potentially decreasing memory and executive function over time. Dr. Thakkar also discusses the complexities of substance use in diverse populations, mentioning increased use in gender-diverse and racially diverse adolescents, often linked to broader societal stressors.<br /><br />Highlighting cannabis, she notes its increased THC potency and links to risks like reduced IQ and psychosis. Alcohol's neurotoxic effects are outlined, with an emphasis on how heavy use can alter adolescent brain function, even leading to structural changes. She also touches on the nuances of opioid use and addiction.<br /><br />The session underscores the importance of targeted prevention and education to mitigate the risk of substance use disorders among adolescents.
Keywords
adolescent substance use
brain development
prefrontal cortex
nicotine
cannabis
alcohol
opioids
diverse populations
prevention education
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English